ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
2.010
+0.100 (5.24%)
At close: Apr 15, 2026, 4:00 PM EDT
2.028
+0.018 (0.90%)
Pre-market: Apr 16, 2026, 8:41 AM EDT
ProKidney Stock Forecast
Stock Price Forecast
The 5 analysts that cover ProKidney stock have a consensus rating of "Strong Buy" and an average price target of $7.40, which forecasts a 268.16% increase in the stock price over the next year. The lowest target is $1.00 and the highest is $12.
Price Target: $7.40 (+268.16%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 16, 2025.
Analyst Ratings
The average analyst rating for ProKidney stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +497.01% | Dec 16, 2025 |
| UBS | UBS | Strong Buy Maintains $4 → $8 | Strong Buy | Maintains | $4 → $8 | +298.01% | Jul 15, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $6 → $7 | Strong Buy | Maintains | $6 → $7 | +248.26% | Jul 14, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $6 → $9 | Strong Buy | Maintains | $6 → $9 | +347.76% | Jul 9, 2025 |
| B of A Securities | B of A Securities | Hold → Sell Downgrades $3 → $1 | Hold → Sell | Downgrades | $3 → $1 | -50.25% | Jun 30, 2025 |
Financial Forecast
Revenue This Year
309.74K
from 893.00K
Decreased by -65.31%
Revenue Next Year
291.72K
from 309.74K
Decreased by -5.82%
EPS This Year
-0.59
from -0.52
EPS Next Year
-0.71
from -0.59
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 840,000 | 840,000 | |||
| Avg | 309,743 | 291,720 | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -5.9% | 171.2% | |||
| Avg | -65.3% | -5.8% | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.53 | -0.44 | |||
| Avg | -0.59 | -0.71 | |||
| Low | -0.70 | -1.31 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.